AGP Executive Report
Last update: 2 hours agoWeight-Loss Treatment: China has approved Eli Lilly’s orforglipron, the country’s first oral GLP-1 drug for weight management in eligible adults with obesity or overweight and a related health condition. Healthy Aging: A small Chinese trial found that eight weeks of the probiotic Pediococcus acidilactici PA53 was linked to better mood, sleep and digestion in adults aged 55–70; researchers say larger studies are needed. Elder Care: Shanghai’s Silver Tech Industry Week put technology-enabled care in the spotlight, while experts flagged a need to design products around older people’s real needs. Air Quality: A Beijing orange smog alert warned of dangerous pollution, reportedly reaching 10 times the WHO daily guideline and putting about 100 million people at risk. Care Access: Ningxia is using telemedicine to connect patients with medical help across the region. Workplace Health: China’s labour law bars hazardous duties for pregnant and breastfeeding workers and requires regular health checks for employees aged 16–17.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
